Completed PHASE3 INTERVENTIONAL 2-arm NCT02151734

Safety and Efficacy of KALOMIN™ Tab. in Patients With Acute Bronchitis

Sponsor: Korea United Pharm. Inc.

Interventions KALOMIN™ Tab. Umckamin syrup

Updated 4 times since 2017 Last updated: May 28, 2014 Started: Aug 31, 2013 Primary completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02151734, this PHASE3 trial focuses on Acute Bronchitis and remains completed. Sponsored by Korea United Pharm. Inc., it has been updated 4 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2017 — Jan 2021 [monthly]

Completed PHASE3

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea United Pharm. Inc.

Data source: Korea United Pharm. Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.